Scientists have devised a new approach to defeating asthma by targeting the trigger - allergen - before it can spark an attack.
Current asthma treatments can alleviate wheezing, coughing and other symptoms felt by the patients, but they do not get to the root cause of the condition.
"To prevent many health problems, the ideal approach to treatment or prevention involves getting to the cause of a condition and targeting it directly," said Clive Robinson from St George's, University of London.
Scientists have found that dust mites are one of the most important triggers of allergic asthma.
So Robinson and his team wanted to find a way to neutralise mite allergens.
They identified a compound that binds to a major dust mite allergen and turned it into an inhalable powder.
They tested it on rats and found that it significantly dampened the animals' immune response when they were exposed to a variety of allergens.
This compound and other similar inhibitors could hail a new direction in asthma treatment, concluded the research.
They findings appeared in the Journal of Medicinal Chemistry.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
